Gilman Hill Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,408
Closed -$319K 183
2018
Q1
$319K Sell
4,408
-2,567
-37% -$195K 0.14% 128
2017
Q4
$525K Hold
6,975
0.21% 106
2017
Q3
$537K Sell
6,975
-84
-1% -$6.34K 0.22% 104
2017
Q2
$528K Hold
7,059
0.23% 101
2017
Q1
$470K Sell
7,059
-2,485
-26% -$166K 0.2% 108
2016
Q4
$623K Buy
9,544
+458
+5% +$29.7K 0.23% 84
2016
Q3
$643K Buy
9,086
+100
+1% +$7.29K 0.25% 77
2016
Q2
$664K Hold
8,986
0.27% 71
2016
Q1
$583K Buy
8,986
+670
+8% +$45.6K 0.27% 73
2015
Q4
$641K Sell
8,316
-65
-0.8% -$5.16K 0.31% 68
2015
Q3
$690K Buy
8,381
+197
+2% +$17.5K 0.36% 61
2015
Q2
$721K Sell
8,184
-111
-1% -$10.2K 0.34% 67
2015
Q1
$733K Sell
8,295
-56
-0.7% -$4.97K 0.35% 66
2014
Q4
$693K Buy
8,351
+120
+1% +$9.95K 0.35% 63
2014
Q3
$694K Hold
8,231
0.38% 62
2014
Q2
$668K Sell
8,231
-83
-1% -$6.53K 0.35% 62
2014
Q1
$633K Buy
8,314
+2,790
+51% +$203K 0.37% 59
2013
Q4
$398K Buy
5,524
+223
+4% +$15.5K 0.26% 70
2013
Q3
$364K Sell
5,301
-1,674
-24% -$111K 0.26% 65
2013
Q2
$442K Buy
+6,975
New +$454K 0.32% 64

Other funds holding NVS